TONIX PHARMACEUTICALS HLDG C
Q1 2025 13F Holders
Symbol
TNXP
CUSIP
890260839
Type
Equity
Class
COM NEW
Num filings
27
Total reported value, excl. options
$8.53 M
Compare 2025 Q1 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2024 Q4
Manager
Report Date
Value ($000)
Shares
Option Type